Viden Hjem Menneskelig sundhed Viden All Holdning Papirer Populærvidenskab Interviews Filter Therapeutic areas COVID-19 Fordøjelsessundhed Apply Hjem Menneskelig sundhed Viden Mechanism of action of an adjuvanted protein vaccine based on the RBD from SARS-CoV-2 Spike protein Hjem Menneskelig sundhed Viden Safety and Immunogenicity of PHH-1V Booster Against SARS-CoV-2 Variants, Including Omicron Subvariants: Results from a Phase IIb Open-Label Extension Study Hjem Menneskelig sundhed Viden Rethinking optimal immunogens to face SARS-CoV-2. Evolution through vaccination Hjem Menneskelig sundhed Viden Antibody and B-cell responses to PHH-1V81 XBB.1.16-adapted SARS-CoV-2 booster vaccination are associated with variant neutralization Hjem Menneskelig sundhed Viden Immunogenicity and safety of PHH-1V COVID-19 vaccine as a heterologus booster in adolescents Hjem Menneskelig sundhed Viden 34th ECCMID Integrated Symposium, 2024: COVID-19 booster immunization Hjem Menneskelig sundhed Viden Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Hjem Menneskelig sundhed Viden Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Hjem Menneskelig sundhed Viden Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Vis mere
